HealthEquity (HQY) Stock Price, News & Analysis

Company Overview

HealthEquity, Inc. (NASDAQ: HQY) is a leading provider of consumer-directed benefits solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company has established itself as a trusted administrator of Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), Health Reimbursement Arrangements (HRAs) and related benefit programs. HealthEquity operates a cloud-based platform that helps individuals and employers navigate the complexities of pre-tax healthcare spending while complying with federal regulations such as HIPAA and ERISA.

The company’s core offerings include HSA custodial services, FSA and HRA plan administration, COBRA continuation coverage and commuter benefits. Through an integrated digital portal and mobile app, HealthEquity provides participants with real-time account access, educational resources and a health-related debit card. The platform also features tools for reimbursement claims, expense tracking and automated payroll integration, enabling seamless data exchange with major payroll and benefits systems.

HealthEquity serves a diverse client base, ranging from small businesses to large enterprises across all 50 states. Its solutions are designed to streamline benefits administration for employers while empowering employees to take greater control of their healthcare finances. The company supports millions of consumer-directed benefit accounts and collaborates with brokers, third-party administrators and financial institutions to expand its reach and enhance plan offerings nationwide.

Under the leadership of President and Chief Executive Officer Jon Kessler, HealthEquity has pursued strategic acquisitions and product enhancements to bolster its market position. The senior management team combines expertise in financial services, technology development and regulatory compliance. Guided by an experienced board of directors, HealthEquity continues to innovate its platform, aiming to simplify benefits management and promote greater financial wellness for individuals and organizations alike.

Key Stats

• Today's Range: $99.90 to $102.19
• 50-Day Range: $84.40 to $113.06
• 52-Week Range: $65.01 to $116.65
• Volume: 627,812 shs
• Average Volume: 862,960 shs
• Market Capitalization: $8.61 billion
• P/E Ratio: 72.66
• Dividend Yield: N/A
• Price Target: $118.09
• Consensus Rating: Buy

HealthEquity Stock Analysis - MarketRank™

HealthEquity scored higher than 73% of companies evaluated by MarketBeat, and ranked 269th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

HealthEquity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

HealthEquity has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 22.41%

Earnings Growth

Earnings for HealthEquity are expected to grow by 22.41% in the coming year, from $2.32 to $2.84 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of HealthEquity is 72.66, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of HealthEquity is 72.66, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.64.

Price to Earnings Growth Ratio

HealthEquity has a PEG Ratio of 1.57. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

HealthEquity has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

6.18% of the float of HealthEquity has been sold short.

Short Interest Ratio / Days to Cover

HealthEquity has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in HealthEquity has recently decreased by 11.74%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

HealthEquity does not currently pay a dividend.

Dividend Growth

HealthEquity does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

6.18% of the float of HealthEquity has been sold short.

Short Interest Ratio / Days to Cover

HealthEquity has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in HealthEquity has recently decreased by 11.74%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 1.10

News Sentiment

HealthEquity has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for HealthEquity this week, compared to 11 articles on an average week.

Search Interest

Only 1 people have searched for HQY on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, HealthEquity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $32,968,990.00 in company stock.

Percentage Held by Insiders

Only 1.50% of the stock of HealthEquity is held by insiders.

Percentage Held by Institutions

99.55% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

HQY Stock Analysis - Frequently Asked Questions

How have HQY shares performed this year?

HealthEquity's stock was trading at $95.95 at the start of the year. Since then, HQY stock has increased by 3.8% and is now trading at $99.55.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) released its earnings results on Tuesday, June, 3rd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The business earned $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a net margin of 9.80% and a trailing twelve-month return on equity of 11.01%.
Read the conference call transcript.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that HealthEquity investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Netflix (NFLX), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

• Last Earnings: 6/03/2025
• Today: 7/05/2025
• Next Earnings (Estimated): 9/02/2025
• Fiscal Year End: 1/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:HQY
• CIK: 1428336
• Web: www.healthequity.com
• Phone: (801) 727-1000
• Fax: 801-727-1005
• Employees: 3,120
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $118.09
• High Stock Price Target: $130.00
• Low Stock Price Target: $100.00
• Potential Upside/Downside: +18.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.37
• Trailing P/E Ratio: 72.66
• Forward P/E Ratio: 42.91
• P/E Growth: 1.57
• Net Income: $96.70 million
• Net Margins: 9.80%
• Pretax Margin: 12.37%
• Return on Equity: 11.01%
• Return on Assets: 6.77%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 4.06
• Quick Ratio: 4.06

Sales & Book Value

• Annual Sales: $1.20 billion
• Price / Sales: 7.17
• Cash Flow: $4.15 per share
• Price / Cash Flow: 23.96
• Book Value: $24.56 per share
• Price / Book: 4.05

Miscellaneous

• Outstanding Shares: 86,470,000
• Free Float: 85,178,000
• Market Cap: $8.61 billion
• Optionable: Optionable
• Beta: 0.49